Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5078837 | 0.78 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL14247970 | 0.69 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL6766070 | 0.65 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL9497060 | 0.63 | — | — | |
| SCHEMBL18094240 | 0.62 | SMN1; SMN2 (0.35) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL2513135 | 0.61 | SMN1; SMN2 (0.35) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL5077018 | 0.61 | — | — | |
| SCHEMBL14247945 | 0.60 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL6905831 | 0.58 | SMN1; SMN2 (0.32) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL2863484 | 0.57 | LTA4H (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1906911-B1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE & TECH ORG (AU) | 2019-09-25 | — | — | EP | disclosed |
| US-9131681-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-09-15 | — | — | US | disclosed |
| US-9017643-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-04-28 | — | — | US | disclosed |
| US-20150004095-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2015-01-01 | — | — | US | disclosed |
| US-20140322326-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| US-8815291-B2 | Particles comprising a releasable dopant therein | Austrailian Nuclear Science & Technology Organisation (AU) | 2014-08-26 | — | — | US | disclosed |
| US-20080199523-A1 | Emulsion with hydrophilic, hydrophobic phase ; reacted in presence of catalyst; anticancer agents, aids, antiarthritic agents, antidiabetic agents, analgesics | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION | 2008-08-21 | — | — | US | disclosed |
| EP-1906911-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2008-04-09 | — | — | EP | disclosed |
| WO-2006133519-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2006-12-21 | — | — | WO | disclosed |